228 related articles for article (PubMed ID: 11438694)
1. A germ-line Tsc1 mutation causes tumor development and embryonic lethality that are similar, but not identical to, those caused by Tsc2 mutation in mice.
Kobayashi T; Minowa O; Sugitani Y; Takai S; Mitani H; Kobayashi E; Noda T; Hino O
Proc Natl Acad Sci U S A; 2001 Jul; 98(15):8762-7. PubMed ID: 11438694
[TBL] [Abstract][Full Text] [Related]
2. Renal carcinogenesis, hepatic hemangiomatosis, and embryonic lethality caused by a germ-line Tsc2 mutation in mice.
Kobayashi T; Minowa O; Kuno J; Mitani H; Hino O; Noda T
Cancer Res; 1999 Mar; 59(6):1206-11. PubMed ID: 10096549
[TBL] [Abstract][Full Text] [Related]
3. Isolation and characterization of a rat homologue of the human tuberous sclerosis 1 gene (Tsc1) and analysis of its mutations in rat renal carcinomas.
Satake N; Kobayashi T; Kobayashi E; Izumi K; Hino O
Cancer Res; 1999 Feb; 59(4):849-55. PubMed ID: 10029074
[TBL] [Abstract][Full Text] [Related]
4. Analysis of both TSC1 and TSC2 for germline mutations in 126 unrelated patients with tuberous sclerosis.
Niida Y; Lawrence-Smith N; Banwell A; Hammer E; Lewis J; Beauchamp RL; Sims K; Ramesh V; Ozelius L
Hum Mutat; 1999; 14(5):412-22. PubMed ID: 10533067
[TBL] [Abstract][Full Text] [Related]
5. A mouse model of tuberous sclerosis 1 showing background specific early post-natal mortality and metastatic renal cell carcinoma.
Wilson C; Idziaszczyk S; Parry L; Guy C; Griffiths DF; Lazda E; Bayne RA; Smith AJ; Sampson JR; Cheadle JP
Hum Mol Genet; 2005 Jul; 14(13):1839-50. PubMed ID: 15888477
[TBL] [Abstract][Full Text] [Related]
6. Heterozygosity for the tuberous sclerosis complex (TSC) gene products results in increased astrocyte numbers and decreased p27-Kip1 expression in TSC2+/- cells.
Uhlmann EJ; Apicelli AJ; Baldwin RL; Burke SP; Bajenaru ML; Onda H; Kwiatkowski D; Gutmann DH
Oncogene; 2002 Jun; 21(25):4050-9. PubMed ID: 12037687
[TBL] [Abstract][Full Text] [Related]
7. Generation of a conditional disruption of the Tsc2 gene.
Hernandez O; Way S; McKenna J; Gambello MJ
Genesis; 2007 Feb; 45(2):101-6. PubMed ID: 17245776
[TBL] [Abstract][Full Text] [Related]
8. Mutation analysis of the TSC1 and TSC2 genes in Japanese patients with pulmonary lymphangioleiomyomatosis.
Sato T; Seyama K; Fujii H; Maruyama H; Setoguchi Y; Iwakami S; Fukuchi Y; Hino O
J Hum Genet; 2002; 47(1):20-8. PubMed ID: 11829138
[TBL] [Abstract][Full Text] [Related]
9. Mutation spectrum of the 9q34 tuberous sclerosis gene TSC1 in transitional cell carcinoma of the bladder.
Knowles MA; Habuchi T; Kennedy W; Cuthbert-Heavens D
Cancer Res; 2003 Nov; 63(22):7652-6. PubMed ID: 14633685
[TBL] [Abstract][Full Text] [Related]
10. Loss of Tsc1 or Tsc2 induces vascular endothelial growth factor production through mammalian target of rapamycin.
El-Hashemite N; Walker V; Zhang H; Kwiatkowski DJ
Cancer Res; 2003 Sep; 63(17):5173-7. PubMed ID: 14500340
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of a rapamycin analog (CCI-779) and IFN-gamma in tuberous sclerosis mouse models.
Lee L; Sudentas P; Donohue B; Asrican K; Worku A; Walker V; Sun Y; Schmidt K; Albert MS; El-Hashemite N; Lader AS; Onda H; Zhang H; Kwiatkowski DJ; Dabora SL
Genes Chromosomes Cancer; 2005 Mar; 42(3):213-27. PubMed ID: 15578690
[TBL] [Abstract][Full Text] [Related]
12. Analysis of the TSC1 and TSC2 genes in sporadic renal cell carcinomas.
Parry L; Maynard JH; Patel A; Clifford SC; Morrissey C; Maher ER; Cheadle JP; Sampson JR
Br J Cancer; 2001 Oct; 85(8):1226-30. PubMed ID: 11710839
[TBL] [Abstract][Full Text] [Related]
13. Analysis of 65 tuberous sclerosis complex (TSC) patients by TSC2 DGGE, TSC1/TSC2 MLPA, and TSC1 long-range PCR sequencing, and report of 28 novel mutations.
Rendtorff ND; Bjerregaard B; Frödin M; Kjaergaard S; Hove H; Skovby F; Brøndum-Nielsen K; Schwartz M;
Hum Mutat; 2005 Oct; 26(4):374-83. PubMed ID: 16114042
[TBL] [Abstract][Full Text] [Related]
14. Presence of potent transcriptional activation domains in the predisposing tuberous sclerosis (Tsc2) gene product of the Eker rat model.
Tsuchiya H; Orimoto K; Kobayashi K; Hino O
Cancer Res; 1996 Feb; 56(3):429-33. PubMed ID: 8564946
[TBL] [Abstract][Full Text] [Related]
15. The mTOR/S6K signalling pathway: the role of the TSC1/2 tumour suppressor complex and the proto-oncogene Rheb.
Nobukini T; Thomas G
Novartis Found Symp; 2004; 262():148-54; discussion 154-9, 265-8. PubMed ID: 15562827
[TBL] [Abstract][Full Text] [Related]
16. A mouse model of TSC1 reveals sex-dependent lethality from liver hemangiomas, and up-regulation of p70S6 kinase activity in Tsc1 null cells.
Kwiatkowski DJ; Zhang H; Bandura JL; Heiberger KM; Glogauer M; el-Hashemite N; Onda H
Hum Mol Genet; 2002 Mar; 11(5):525-34. PubMed ID: 11875047
[TBL] [Abstract][Full Text] [Related]
17. The transcriptional profile of the kidney in Tsc2 heterozygous mutant Long Evans (Eker) rats compared to wild-type.
Sen B; Wolf DC; Hester SD
Mutat Res; 2004 May; 549(1-2):213-24. PubMed ID: 15120972
[TBL] [Abstract][Full Text] [Related]
18. Induction of renal tumorigenesis with elevated levels of somatic loss of heterozygosity in Tsc1+/- mice on a Blm-deficient background.
Wilson C; Idziaszczyk S; Colley J; Humphreys V; Guy C; Maynard J; Sampson JR; Cheadle JP
Cancer Res; 2005 Nov; 65(22):10179-82. PubMed ID: 16288003
[TBL] [Abstract][Full Text] [Related]
19. Estrogen enhances whereas tamoxifen retards development of Tsc mouse liver hemangioma: a tumor related to renal angiomyolipoma and pulmonary lymphangioleiomyomatosis.
El-Hashemite N; Walker V; Kwiatkowski DJ
Cancer Res; 2005 Mar; 65(6):2474-81. PubMed ID: 15781664
[TBL] [Abstract][Full Text] [Related]
20. Mutational analysis of the TSC1 and TSC2 genes in a diagnostic setting: genotype--phenotype correlations and comparison of diagnostic DNA techniques in Tuberous Sclerosis Complex.
Sancak O; Nellist M; Goedbloed M; Elfferich P; Wouters C; Maat-Kievit A; Zonnenberg B; Verhoef S; Halley D; van den Ouweland A
Eur J Hum Genet; 2005 Jun; 13(6):731-41. PubMed ID: 15798777
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]